Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2018
19th World Conference on Lung Cancer
Access to all presentations that occur during the 19th World Conference on Lung Cancer in Toronto, ON
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2384
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Presentations will be available 24 hours after their live presentation time
-
+
P1.01 - Advanced NSCLC (Not CME Accredited Session)
- Type: Poster Viewing in the Exhibit Hall
- Track:
- Presentations: 112
- Coordinates: 9/24/2018, 16:45 - 18:00, Exhibit Hall
-
+
P1.01-21 - Safety of Durvalumab Retreatment in Advanced NSCLC Patients Who Progressed Following Initial Disease Control In ATLANTIC
16:45 - 18:00 | Presenter: Marina Chiara Garassino
- Abstract
Loading...
-
+
MS14 - IO in Early Stage NSCLC
- Type: Mini Symposium
- Track: Immunooncology
- Presentations: 6
- Coordinates: 9/25/2018, 10:30 - 12:00, Room 107
-
+
MS14.05 - Do Biomarkers used in Metastatic Setting Apply in Earlier Stages
11:30 - 11:45 | Presenter: Naiyer A Rizvi
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P2.01 - Advanced NSCLC (Not CME Accredited Session)
- Type: Poster Viewing in the Exhibit Hall
- Track:
- Presentations: 132
- Coordinates: 9/25/2018, 16:45 - 18:00, Exhibit Hall
-
+
P2.01-33 - Open-Label, Biomarker-Directed Platform Study in NSCLC Patients Who Progressed on an Anti-PD-(L)1 Containing Therapy (HUDSON)
16:45 - 18:00 | Presenter: Patrick M Forde
- Abstract
Loading...
-
+
P2.17 - Treatment of Locoregional Disease - NSCLC (Not CME Accredited Session)
- Type: Poster Viewing in the Exhibit Hall
- Track:
- Presentations: 33
- Coordinates: 9/25/2018, 16:45 - 18:00, Exhibit Hall
-
+
P2.17-27 - IMpower030: Phase III Study Evaluating Neoadjuvant Treatment of Resectable Stage II-IIIB NSCLC with Atezolizumab + Chemotherapy
16:45 - 18:00 | Presenter: Naiyer A Rizvi
- Abstract
Loading...
-
+
EX04 - Mini Oral Abstract Session - MA08.06, MA18.02, MA19.02, MA20.11
- Type: Exhibit Showcase
- Track: Advanced NSCLC
- Presentations: 5
- Coordinates: 9/26/2018, 09:55 - 10:25, Exhibit Showcase Theater
-
+
EX04.03 - Prior Therapy and Increased Expression of PD-L1 in NSCLC Tumor Samples
10:05 - 10:10 | Presenter: Anne-Marie Boothman
- Abstract
Loading...
-
+
P3.04 - Immunooncology (Not CME Accredited Session)
- Type: Poster Viewing in the Exhibit Hall
- Track:
- Presentations: 29
- Coordinates: 9/26/2018, 12:00 - 13:30, Exhibit Hall
-
+
P3.04-23 - Phase 1b/2 Study to Evaluate Novel Combinations With Oleclumab (MEDI9447) in Previously Treated Advanced EGFRm NSCLC
12:00 - 13:30 | Presenter: Naiyer A Rizvi
- Abstract
Loading... -
+
P3.04-24 - EMPOWER-Lung 2: Cemiplimab and Ipilimumab ± Chemotherapy vs Pembrolizumab in Advanced NSCLC with PD-L1 ≥50%, a Phase 3 Study
12:00 - 13:30 | Presenter: Naiyer A Rizvi
- Abstract
Loading... -
+
P3.04-25 - EMPOWER-Lung 3: A Phase 3 Study of Cemiplimab, Ipilimumab and Chemotherapy in Advanced NSCLC with PD-L1 <50%
12:00 - 13:30 | Presenter: Naiyer A Rizvi
- Abstract
Loading... -
+
P3.04-26 - EMPOWER-Lung 4: A Phase 2 Study of Cemiplimab Plus Ipilimumab in the Second-Line Treatment of Advanced NSCLC with PD-L1 <50%
12:00 - 13:30 | Presenter: Naiyer A Rizvi
- Abstract
Loading...
